HWA
VRTX icon

Heritage Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Heritage Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Hold
38
– – ﹤0.01% 448
2026
Q1 		$17K Buy
38
+35
+1,167% +$16.3K ﹤0.01% 459
2025
Q4 		$1.36K Hold
3
– – ﹤0.01% 551
2025
Q3 		$1.18K Sell
3
-50
-94% -$20.9K ﹤0.01% 540
2025
Q2 		$23.6K Hold
53
– – ﹤0.01% 357
2025
Q1 		$25.7K Buy
53
+23
+77% +$10.7K ﹤0.01% 349
2024
Q4 		$12.1K Buy
30
+23
+329% +$10.7K ﹤0.01% 429
2024
Q3 		$3.26K Buy
+7
New +$3.36K ﹤0.01% 519
2020
Q1 		– Sell
-7
Closed -$1.53K – 586
2019
Q4 		$1.53K Buy
+7
New +$1.42K ﹤0.01% 607

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Heritage Wealth Advisors's VRTX Position: Q2 2026 in Review

Heritage Wealth Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 38 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Heritage Wealth Advisors first reported a position in VRTX in Q4 2019 and has held it in 9 quarters since. The position peaked at $25.7K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Heritage Wealth Advisors held 38 shares of Vertex Pharmaceuticals worth $18.9K as of Q2 2026.
  • Heritage Wealth Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q2 2026, its #448 holding.
  • Heritage Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 9 quarters since.
  • Heritage Wealth Advisors's Vertex Pharmaceuticals position peaked at $25.7K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Heritage Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.